The main goal of the medical therapy of DJD is to restore and maintain
normal joint function by alleviating joint pain, decreasing joint inf
lammation, and protecting the cartilage from further injury. The role
of substances termed ''chondroprotective agents'' that counter the des
tructive inflammatory process and encourage normalization of the synov
ial fluid and cartilage matrix is explored in this paper.